• Home
  • Resources
  • CME
  • Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors

Project ECHO®: Endocrine Toxicities
with Immune Checkpoint Inhibitors

Telementoring To Manage Immune-related Adverse Events
in Patients Receiving Cancer Immunotherapies

Session 3 — Endocrinology


  • CME Information or Content Source:
    Content Derived from a CME Certified Webinar in November 2022
  • Event Sponsor(s):

    This activity is supported by an educational grant from Bristol Myers Squibb

  • Event Details:

    Program provided by Boston University (BU) and Association of Community Cancer Centers (ACCC)


  • Date Recorded:
    November 15, 2022
  • Recording Length:
    51:49

Speakers

Jocelyn E. Mohs, PharmD, BCOP
Director of Pharmacy
Sanford Medical Center, Fargo
Fargo, ND

Rajeev Sharma, MD
Assistant Professor of Oncology & Medicine
Division of Endocrinology
Roswell Park Comprehensive Cancer Center
Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, NY

Learning Objectives

At the end of this educational program, participants should be able to:

  • Apply evidence-based practices for the monitoring and management of immune-related adverse events (irAE) in patients receiving cancer immunotherapies
  • Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
  • Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies

Click here to learn about remaining Project ECHO sessions or to view other available recordings.